Literature DB >> 17117483

Early inflammatory arthritis in the rabbit: the influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissues of the knee.

Alison S Kydd1, Carol R Reno, Helen W Tsao, David A Hart.   

Abstract

OBJECTIVE: Using a rabbit model of inflammatory arthritis, to determine the influence of early disease on expression of specific genes and investigate the influence of intraarticular (IA) and intramuscular (IM) corticosteroids on the regulation of these genes in connective tissues of the rabbit knee.
METHODS: Skeletally mature rabbits underwent induction of antigen-induced arthritis or remained untreated as control animals. Four days after disease induction, at an early stage of the disease, animals underwent either IA or IM treatment with glucocorticoids (GC) (5 mg/knee and 10 mg/kg methylprednisolone acetate, respectively). Twenty-four hours following treatment, synovium, menisci, and cartilage of the knee were collected and analyzed for changes in mRNA levels using reverse transcription-polymerase chain reaction for a number of relevant genes: collagen I, collagen II, biglycan, decorin, matrix metalloproteinases-3 and -13 (MMP-3 and MMP-13), cyclooxygenases-1 and -2 (COX-1 and COX-2), tumor necrosis factor-alpha (TNF-alpha), interleukin 1beta (IL-1beta), inducible nitric oxide synthase (iNOS), hyaluronan synthase-2 (HAS-2), and the housekeeping gene beta-actin.
RESULTS: Early inflammatory arthritis led to an overall upregulation of most genes assessed, but a downregulation of some genes (iNOS, HAS-2, COX-1) in some tissues. While genes such as collagen II, MMP-3, and MMP-13 were uniformly downregulated by GC treatment in both normal and arthritic tissues, other genes such as collagen I, biglycan, and decorin differed in their pattern of response depending on the tissue examined, the route of drug administration, and whether normal or arthritic tissue was studied.
CONCLUSION: Early mRNA changes in RA-like disease led to alterations in all tissues examined. The changes were uniquely altered by GC treatment. Route of GC administration influenced outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117483

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Methylprednisolone acetate mitigates IL1β induced changes in matrix metalloproteinase gene expression in skeletally immature ovine explant knee tissues.

Authors:  Kristen I Barton; May Chung; Cyril B Frank; Nigel G Shrive; David A Hart
Journal:  Inflamm Res       Date:  2020-11-23       Impact factor: 4.575

2.  Location and gene-specific effects of methylprednisolone acetate on mitigating IL1β-induced inflammation in mature ovine explant knee tissue.

Authors:  Kristen I Barton; Bryan J Heard; May Chung; Johnathan L Sevick; C Ryan Martin; Yamini Achari; Cyril B Frank; Nigel G Shrive; David A Hart
Journal:  Inflamm Res       Date:  2016-11-16       Impact factor: 4.575

3.  Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits.

Authors:  Linda S Liang; Paul T Salo; David A Hart; Helen M Burt
Journal:  Inflamm Res       Date:  2009-03-06       Impact factor: 4.575

4.  Carrageenan-induced transient inflammation in a rabbit knee model: molecular changes consistent with an early osteoarthritis phenotype.

Authors:  Yamini Achari; Carol R Reno; Cyril B Frank; David A Hart
Journal:  Inflamm Res       Date:  2012-05-13       Impact factor: 4.575

5.  Hormonal modulation of connective tissue homeostasis and sex differences in risk for osteoarthritis of the knee.

Authors:  Barbara D Boyan; David A Hart; Roger M Enoka; Daniel P Nicolella; Eileen Resnick; Karen J Berkley; Kathleen A Sluka; C Kent Kwoh; Laura L Tosi; Mary I O'Connor; Richard D Coutts; Wendy M Kohrt
Journal:  Biol Sex Differ       Date:  2013-02-04       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.